Skip to content

Study on the application of Single-molecule Array in detecting blood-based pathological markers in Alzheimer's disease

Study on the application of Single-molecule Array in detecting blood-based pathological markers in Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035898
Enrollment
Unknown
Registered
2020-08-19
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Gold Standard:Clinical outcome based on the PET scan
Index test:Simoa&#32
technology&#32
in&#32
and&#32
protein&#32

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants are willing to sign an informed consent form, aged 50 to 80 years; no anxiety, depression and other mental disorders in the past month, normal hearing and vision, cooperation in cognitive examination, no contraindications to complete MRI. MRI examination of the head showed only varying degrees of brain atrophy, without lacunar infarction, patchy or diffuse leukoaraiosis.

Exclusion criteria

Exclusion criteria: A clear history of stroke, brain tumors, hydrocephalus, brain trauma and other brain diseases, serious physical diseases.

Design outcomes

Primary

MeasureTime frame
Peripheral blood A beta 40;The levels of Aß42 in peripheral blood;T-tau levels in peripheral blood;P-tau levels in peripheral blood;;Nfl level in peripheral blood;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactGuo Qihao

Shanghai Sixth People's Hospital

Dr.guoqihao@126.com+86 13817741448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026